The genetic ablation of Atxn2 in mice does not lead to a neurodegenerative process with weight loss such as SCA2, but instead to obesity, lipid anomalies, and insulin resistance [47, 48]. The gene discussed is ATXN2; the disease is obesity due to melanocortin 4 receptor deficiency.